Evidence map›Paper›PMID 40160859›Full record

ArticleComputational and structural biotechnology journal2025

GL4SDA: Predicting snoRNA-disease associations using GNNs and LLM embeddings.

Massimo La Rosa, Antonino Fiannaca, Isabella Mendolia, Laura La Paglia, Alfonso Urso

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Massimo La RosaCNR-ICAR, National Research Council of Italy, via Ugo La Malfa 153, Palermo, 90146, Italy.
Antonino FiannacaCNR-ICAR, National Research Council of Italy, via Ugo La Malfa 153, Palermo, 90146, Italy.
Isabella MendoliaCNR-ICAR, National Research Council of Italy, via Ugo La Malfa 153, Palermo, 90146, Italy.
Laura La PagliaCNR-ICAR, National Research Council of Italy, via Ugo La Malfa 153, Palermo, 90146, Italy.
Alfonso UrsoCNR-ICAR, National Research Council of Italy, via Ugo La Malfa 153, Palermo, 90146, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small nucleolar RNAs (snoRNAs) play essential roles in various cellular processes, and their associations with diseases are increasingly recognized. Identifying these snoRNA-disease relationships is critical for advancing our understanding of their functional roles and potential therapeutic implications. This work presents a novel approach, called GL4SDA, to predict snoRNA-disease associations using Graph Neural Networks (GNN) and Large Language Models. Our methodology leverages the unique strengths of heterogeneous graph structures to model complex biological interactions. Differently from existing methods, we define a set of features able to capture deeper information content related to the inner attributes of both snoRNAs and diseases and design a GNN model based on highly performing layers, which can maximize results on this representation. We consider snoRNA secondary structures and disease embeddings derived from large language models to obtain snoRNAs and disease node features, respectively. By combining structural features of snoRNAs with rich semantic embeddings of diseases, we construct a feature-rich graph representation that improves the predictive performance of our model. We evaluate our approach using different architectures that exploit the capabilities of many graph convolutional layers and compare the results with three other state-of-the-art graph-based predictors. GL4SDA demonstrates improved scores in link prediction tasks and demonstrates its potential implication as a tool for exploring snoRNA-disease relationships. We also validate our findings through biological case studies about cancer diseases, highlighting the practical application of our method in real-world scenarios and obtaining the most important snoRNA features using explainable artificial intelligence methods.

Indexed as

BioinformaticsDiseaseGNNLLMMachine learningPredictionsnoRNA

Identifiers

PMID40160859
PMCPMC11952811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.